Thromb Haemost 2015; 114(03): 655
DOI: 10.1160/TH15-02-0101
Letters to the Editor
Schattauer GmbH

Atrial fibrillation is not associated with increased risk of venous thromboembolism: Results from ARAPACIS study

Stefania Basili
1   I Clinica Medica, Sapienza University Of Rome, Italy
,
Marco Proietti
1   I Clinica Medica, Sapienza University Of Rome, Italy
2   University of Birmingham, Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK
,
Francesco Perticone
3   University of Catanzaro, Catanzaro, Italy
,
Gino Roberto Corazza
4   First Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
,
Francesco Violi
1   I Clinica Medica, Sapienza University Of Rome, Italy
,
the ARAPACIS Study Investigators › Author Affiliations
Further Information

Publication History

Received: 05 February 2015

Accepted after major revision: 13 April 2015

Publication Date:
21 November 2017 (online)

 

 
  • References

  • 1 Wang CC, Lin CL, Wang GJ. et al. Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study. Thromb Haemost 2015; 113: 185-192.
  • 2 Violi F, Daví G, Hiatt W. et al. Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. J Am Coll Cardiol 2013; 62: 2255-2256.
  • 3 Heit JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Hae-most 2005; 03: 1611-1617.
  • 4 Raparelli V, Proietti M, Buttà C. et al. Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study. Intern Emerg Med 2014; 09: 861-870.
  • 5 Di Nisio M, Porreca E, Otten HM. et al. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Cochrane Database Syst Rev 2014; 08: CD008500.